Medici List crest

Aeluma, Inc.

CIK: 18288052 Annual ReportsLatest: 2026-09-16
Revenue: $4,461,000Net Income: -$9,159,000Source 10-K
Disclaimer: AI-assisted summary of SEC Form 10-K filings. Not official company content and not investment, legal, accounting, or tax advice. See full disclaimer here.

10-K / September 16, 2026

Revenue:$4,461,000
Income:-$9,159,000

10-K / September 27, 2024

Revenue:$918,554
Income:-$4,562,295

10-K / September 16, 2026

Aeluma, Inc.

Overview

Aeluma develops high-performance photonic and electronic technologies for communications and sensing across telecom, AI datacom, mobile, defense/aerospace, robotics, automotive, AR/VR, and quantum applications. The company focuses on heterogeneous integration of compound semiconductor materials on large-diameter substrates to align with mainstream microelectronics manufacturing.

Platform drivers and technology

  • Heterogeneous integration of compound semiconductors on large-diameter substrates (e.g., silicon and GaAs).
  • Photodetectors and photodetector arrays for near-infrared (NIR) and shortwave infrared (SWIR) detection.
  • Quantum dot lasers and related nonlinear photonics for optical communications and sensing.
  • Platform extensibility to other photonic and electronic devices, including transistors and solar cells.
  • Compatibility with silicon and silicon nitride photonics for integrated photonic systems.

Products and applications

  • Photodetectors and imaging arrays capable of NIR and SWIR detection.
  • Quantum dot–based lasers and optical amplifiers.
  • Nonlinear photonics components and integration-ready devices for communications and sensing systems.

Manufacturing and facilities

  • Internal capabilities include materials growth, process development, prototyping, wafer-level testing, and validation.
  • Production-scale activities rely on external foundries and packaging/integration partners; the company aims to qualify repeatable production flows with those partners.
  • 2026 expansion included acquisition of automated and semi-automated wafer probers, packaging and prototyping equipment, test and validation instruments, and expanded outsourced wafer fabrication.
  • Primary facilities total approximately 9,000 square feet for R&D and manufacturing with a cleanroom; the lease is extended through March 2031.
  • Additional office space of about 2,400 square feet is located near headquarters.

Commercial and industrial strategy

  • Capital-efficient model: maintain internal materials growth, process development, prototyping, and wafer testing while using external foundries and packaging partners for production scale.
  • Strategic relationships with external foundries and partners were announced in 2026 with Tower Semiconductor and Sumitomo Chemical Advanced Technologies for wafer production and fabrication.
  • Transitioning from primarily government-funded R&D toward commercialization. The company has delivered engineering samples, wafers, and chips, has completed NRE projects, and has begun accepting initial commercial orders.

Customers and markets

  • Target customers include U.S. government agencies and prime contractors, semiconductor and optical component suppliers, system integrators, module manufacturers, Tier-1 suppliers, and manufacturers in mobile/consumer electronics, data-center/communications equipment, defense/aerospace systems, and quantum technologies.
  • Customer engagement increased in AI datacom, mobile/consumer electronics, defense/aerospace, and quantum applications during fiscal year 2026; the company has delivered wafers, chips, and engineering samples and performed customer-funded development work. Initial commercial orders have been small.

Intellectual property

  • IP portfolio of approximately 36 issued and pending patents covering heterogeneous integration on large-diameter substrates, scalable manufacturing, photodetectors and imaging arrays, photonic components, 3D sensing, large-format imaging, quantum dot lasers, and integrated semiconductor platforms.
  • Additional protections include trade secrets, know-how, and confidential information, plus trademark applications for “Aeluma” and “Sensing Reimagined.”

People and location

  • 27 employees as of June 30, 2026 (24 full-time), all based in the United States.
  • Hiring priorities focused on engineering, manufacturing, and business development. No employees are under a collective bargaining agreement.

Funding and regulatory programs

  • Entered into a letter of intent with the U.S. Department of Commerce for proposed CHIPS and Science Act funding; the funding is milestone-based.
  • Export controls and other regulatory considerations are relevant to the company’s government and commercial activities.

Operational considerations and strategic goals

  • Operations are concentrated in Goleta, California, and the company relies on third-party foundries and suppliers for some production activities.
  • Strategic goals include advancing a differentiated heterogeneous integration platform, focusing on high-value markets (AI datacom, defense/aerospace, quantum, mobile/consumer), scaling through a capital-efficient ecosystem, accessing government programs and customer-funded development, forming strategic partnerships, protecting IP, and building organizational capability.